Search research articles
Contact Us
Filters
Showing results (221-230 of 418) with videos related to
Page
of 42
Sort By:
Cancers
|
May 14, 2022
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma
Krisztian Homicsko, Reinhard Dummer, Christoph Hoeller, et al.
Journal for Immunotherapy of Cancer
|
September 16, 2022
Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis
James L Alexander, Hajir Ibraheim, Camellia Richards, et al.
JCO Precision Oncology
|
February 9, 2022
Effects of Molecular Heterogeneity on Survival of Patients With <i>BRAF</i><sup>V600</sup>-Mutated Melanoma Treated With Vemurafenib With or Without Cobimetinib in the coBRIM Study
Matthew J Wongchenko, Antoni Ribas, Paolo A Ascierto, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 31, 2017
Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017
Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Cancer Cell
|
August 16, 2011
ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma
Victoria Sanz-Moreno, Cedric Gaggioli, Maggie Yeo, et al.
Cancer Discovery
|
December 18, 2012
Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma
Maria R Girotti, Malin Pedersen, Berta Sanchez-Laorden, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 29, 2015
Survival of patients with advanced metastatic melanoma: The impact of novel therapies
Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Journal for Immunotherapy of Cancer
|
July 11, 2025
Pretreatment and on-treatment ctDNA and tissue biomarkers predict recurrence in patients with stage IIIB-D/IV melanoma treated with adjuvant immunotherapy: CheckMate 915
Georgina V Long, Hao Tang, Keyur Desai, et al.
Clinical Kidney Journal
|
October 1, 2025
But how green is it actually? Calculating the environmental footprint of kidney care environmental optimizations within haemodialysis
Brett Duane, James Larkin, Marialuisa Caiazzo, et al.
International Urology and Nephrology
|
February 3, 2026
Comparing environmental footprints of haemodialysis and online haemodiafiltration in Italy
James Larkin, Giulia Ligabue, Niccolo Morisi, et al.
Page
of 42
Search research articles
Search
Showing results (221-230 of 418) with videos related to
Sort By:
Page
of 42
Cancers
|
May 14, 2022
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma
Krisztian Homicsko, Reinhard Dummer, Christoph Hoeller, et al.
Journal for Immunotherapy of Cancer
|
September 16, 2022
Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis
James L Alexander, Hajir Ibraheim, Camellia Richards, et al.
JCO Precision Oncology
|
February 9, 2022
Effects of Molecular Heterogeneity on Survival of Patients With <i>BRAF</i><sup>V600</sup>-Mutated Melanoma Treated With Vemurafenib With or Without Cobimetinib in the coBRIM Study
Matthew J Wongchenko, Antoni Ribas, Paolo A Ascierto, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 31, 2017
Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017
Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Cancer Cell
|
August 16, 2011
ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma
Victoria Sanz-Moreno, Cedric Gaggioli, Maggie Yeo, et al.
Cancer Discovery
|
December 18, 2012
Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma
Maria R Girotti, Malin Pedersen, Berta Sanchez-Laorden, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 29, 2015
Survival of patients with advanced metastatic melanoma: The impact of novel therapies
Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Journal for Immunotherapy of Cancer
|
July 11, 2025
Pretreatment and on-treatment ctDNA and tissue biomarkers predict recurrence in patients with stage IIIB-D/IV melanoma treated with adjuvant immunotherapy: CheckMate 915
Georgina V Long, Hao Tang, Keyur Desai, et al.
Clinical Kidney Journal
|
October 1, 2025
But how green is it actually? Calculating the environmental footprint of kidney care environmental optimizations within haemodialysis
Brett Duane, James Larkin, Marialuisa Caiazzo, et al.
International Urology and Nephrology
|
February 3, 2026
Comparing environmental footprints of haemodialysis and online haemodiafiltration in Italy
James Larkin, Giulia Ligabue, Niccolo Morisi, et al.
Page
of 42